Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8318700
Lung-targeted drugs
granted -
US 8318182
Vault compositions for immunization against Chlamydia genital infection
granted -
US 8309350
Photoreactive regulator of protein function and methods of use thereof
granted -
US 8309525
Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof
granted -
US 8309565
Phosphonate compounds
granted -
US 8309355
Methods of treating Parkinson's disease using viral vectors
granted -
US 8304408
Wnt signaling inhibitors, and methods for making and using them
granted -
US 8298556
Methods and related compositions for the non-surgical removal of fat
granted -
US 8298606
Methods and compositions for stabilizing the myocardium
granted -
US 8299218
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
granted -
US 8299046
Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
granted -
US 8298521
Treatment for eye disorder
granted -
US 8293764
Compositions and methods for disruption of BRCA2-Rad51 interaction
granted -
US 8287879
Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
granted -
US 8283308
Copolymer-stabilized emulsions
granted -
US 8277797
Interferon-β production modulating Listeria strains and methods for using same
granted -
US 8273867
Transducible delivery of siRNA by dsRNA binding domain fusions to PTD/CPPS
granted -
US 8274643
Porous nanostructures and methods involving the same
granted -
US 8263651
Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors
granted -
US 8263085
Gammaretrovirus associated with cancer
granted -
US 8263747
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
granted -
US 8263662
Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
granted -
US 8263133
Multivalent clustering targeting strategy for drug carriers
granted -
US 8263661
Development of new selective estrogen receptor modulators
granted